Pro Medicus Shares Rise Following AU$30 Million Contract with Duly Health and Care

3 min read | December 23, 2024 10:59 AM AEDT | By Team Kalkine Media

Highlights

  • AU$30 Million Contract Signed: Pro Medicus secures a seven-year deal with Duly Health and Care, the largest physician-directed medical group in the U.S. Midwest.
  • Cloud-Based Imaging Platform Rollout: The deal includes implementing Pro Medicus' Visage 7 Enterprise Imaging Platform across DHC’s network.
  • Completion Timeline: Migration to the new system is expected by Q2 2025, with immediate planning underway.

Shares of Pro Medicus Limited (ASX:PME) began the week on a high note, rising 1.5% in morning trade to AU$251.90. This uptick follows the announcement of a significant seven-year contract worth AU$30 million with Duly Health and Care (DHC), a major U.S.-based healthcare group.

Deal Overview

DHC, known for its brands DuPage Medical Group, Quincy Medical Group, and The South Bend Clinic, is the largest independent, multi-specialty, physician-directed medical group in the Midwest. Its network includes over 40 radiologists, 1,000 physicians, and 150 outpatient clinics.

Under the agreement, Pro Medicus will deploy its cloud-engineered Visage 7 Enterprise Imaging Platform, which includes the Visage 7 Open Archive and Visage 7 Workflow modules, across DHC's extensive operations. This unified diagnostic imaging platform will replace DHC’s legacy PACS archive and vendor-neutral archive.

The implementation process is set to begin immediately, leveraging Pro Medicus' proven cloud-based strategy. Full migration to the Visage 7 Open Archive is expected to be completed by the second quarter of 2025.

Strategic Importance

Dr. Sam Hupert, CEO of Pro Medicus, expressed enthusiasm about the deal, emphasizing its significance in the private radiology and outpatient sector. He stated:
"Duly Health and Care is an important deal for us as they are in the private radiology/outpatient space, an area of the market where we are starting to see increased opportunity. They also join a long list of Visage 7 clients to opt for a fully cloud-engineered solution, which, as a result of our CloudPACS strategy, is becoming the standard in the North American healthcare IT market."

Dr. Hupert also highlighted the growing demand for Pro Medicus' full-stack offerings, which include the viewer, workflow, and archive modules. This trend aligns with the company’s strategy to provide comprehensive, cloud-based imaging solutions.

Market Potential

The agreement with DHC marks another milestone in Pro Medicus’ expanding presence in the North American healthcare IT market. The company’s Visage 7 platform is rapidly gaining traction across various market segments, including academic medical centers, integrated delivery networks (IDNs), and private/teleradiology practices.

Dr. Hupert added:
"Our pipeline remains strong and spans all market segments including academic medical centers, IDNs, and the private/teleradiology market. This deal reinforces the growing adoption of our 'full stack' solutions."

Investor Reaction

Investors responded positively to the announcement, with Pro Medicus shares climbing in early trade.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.